Rhenman & Partners Asset Management Ab Axonics, Inc. Transaction History

Rhenman & Partners Asset Management Ab

$1.2 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$49.38 - $63.75 $493,800 - $637,500	-10,000 Reduced 4.35%	220,000 $13.7 Million
Q2 2023 Aug 11, 2023	SELL	$47.99 - $60.21 $1.97 Million - $2.47 Million	-41,062 Reduced 15.15%	230,000 $11.6 Million
Q1 2023 May 11, 2023	BUY	$52.6 - $67.34 $2.16 Million - $2.77 Million	41,062 Added 17.85%	271,062 $14.8 Million
Q4 2022 Feb 13, 2023	BUY	$59.56 - $76.6 $1.19 Million - $1.53 Million	20,000 Added 9.52%	230,000 $14.4 Million
Q3 2022 Nov 14, 2022	SELL	$57.96 - $78.12 $1.74 Million - $2.34 Million	-30,000 Reduced 12.5%	210,000 $15.4 Million
Q1 2022 May 13, 2022	SELL	$43.74 - $62.76 $3.28 Million - $4.71 Million	-75,000 Reduced 23.81%	240,000 $15 Million
Q4 2021 Feb 11, 2022	BUY	$50.01 - $73.35 $1.25 Million - $1.83 Million	25,000 Added 8.62%	315,000 $17.7 Million
Q3 2021 Nov 12, 2021	SELL	$59.21 - $78.66 $5.33 Million - $7.08 Million	-90,000 Reduced 23.68%	290,000 $18.9 Million
Q2 2021 Aug 13, 2021	SELL	$51.39 - $66.9 $1.54 Million - $2.01 Million	-30,000 Reduced 7.32%	380,000 $24.1 Million
Q1 2021 May 14, 2021	SELL	$49.14 - $59.89 $2.46 Million - $2.99 Million	-50,000 Reduced 10.87%	410,000 $24.6 Million
Q3 2020 Oct 13, 2020	SELL	$35.33 - $51.04 $353,300 - $510,400	-10,000 Reduced 2.13%	460,000 $23.5 Million
Q2 2020 Jul 16, 2020	BUY	$22.91 - $39.83 $114,550 - $199,150	5,000 Added 1.08%	470,000 $16.5 Million
Q1 2020 Apr 16, 2020	BUY	$16.44 - $37.73 $2.22 Million - $5.09 Million	135,000 Added 40.91%	465,000 $11.8 Million
Q4 2019 Jan 17, 2020	BUY	$19.57 - $28.96 $6.46 Million - $9.56 Million	330,000 New	330,000 $9.14 Million

Others Institutions Holding AXNX

# of Institutions

217

Shares Held

41.6M

Call Options Held

83.4K

Put Options Held

65.3K

Vanguard Group Inc Valley Forge, PA

5.06M
Shares

$359 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.34M
Shares

$308 Million
0.01% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

2.18M
Shares

$155 Million
6.99% of portfolio
Fil LTD Hamilton, D0

2.04M
Shares

$145 Million
0.14% of portfolio
Westchester Capital Management, LLC Valhalla, NY

1.45M
Shares

$103 Million
4.89% of portfolio

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account